HomeOwner SearchCategory Search
Visit USCOFact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (GS-5734)
Text Registration
Copyright Title
Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (GS-5734)
Status
Published
on 21 May 2020
Year of Creation
2020
Copyright Claimant
Gilead Sciences, Inc
Registration Number
TX0008870867
on 21 May 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008870867) dated 21 May 2020, pertains to an electronic file (eService) titled "Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (GS-5734)" created in 2020. The copyright holder is Gilead Sciences, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Gilead Sciences, Inc.
Application Details
Registration Number
TX0008870867
Registration Date
5/21/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Gilead Sciences, Inc
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, tmteam@gilead.com
Statements
Application Title Statement: Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (GS-5734)
Author Statement: Gilead Sciences, Inc employer for hire Domicile: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.